The group and a PE institution jointly made a round of A round investment in a biotechnology enterprise in Zhejiang, helping it with the clinical trials and registration of a series of three types of medical devices, as well as the R & D of other urinary tumor pipeline products and the optimization and upgrading of its core technology platform.
The group adheres to the concept of "caring for health and focusing on medical treatment", takes promoting the development of medical and health undertakings as its mission, focuses on providing investment from domestic and foreign advanced and professional medical device companies through continuous market cultivation, and benefits domestic patients.
